# Volkmar Müller

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/volkmar-muller/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,412 |
| Field | Breast Cancer Treatment Studies |
| h-index | 83 |
| i10-index | 361 |
| Last Known Institution | Universität Hamburg |
| OpenAlex ID | https://openalex.org/A5108388715 |
| ORCID iD | https://orcid.org/0000-0003-4231-7906 |
| Works | 1,171 |

## Researcher papers

- [Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer](https://scholariq.org/papers/tucatinib-trastuzumab-and-capecitabine-for-her2-positive-metastatic-breast/)
- [A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors](https://scholariq.org/papers/a-new-molecular-predictor-of-distant-recurrence-in-er-positive-her2-negative/)
- [Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial](https://scholariq.org/papers/intracranial-efficacy-and-survival-with-tucatinib-plus-trastuzumab-and/)
- [A clinically relevant gene signature in triple negative and basal-like breast cancer](https://scholariq.org/papers/a-clinically-relevant-gene-signature-in-triple-negative-and-basal-like-breast/)
- [Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis](https://scholariq.org/papers/circulating-tumor-cells-in-breast-cancer-patients-treated-by-neoadjuvant/)
- [A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors](https://scholariq.org/papers/a-comprehensive-analysis-of-human-gene-expression-profiles-identifies-stromal/)
- [6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)](https://scholariq.org/papers/6th-and-7th-international-consensus-guidelines-for-the-management-of-advanced/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Universität Hamburg](https://scholariq.org/institutions/universitat-hamburg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.